AFX腔内主动脉瘤系统联合VELA覆膜支架的Active Seal技术用于锥形近端瘤颈患者的早期临床结局
本研究回顾性分析了2016年1月至2020年8月日本17家医院使用AFX系统联合VELA覆膜支架行EVAR的锥形近端瘤颈腹主动脉瘤患者,核心实验室确认纯锥形颈者39例,Active Seal技术显著延长近端封闭区,12个月内无1a型和3型内漏,近端瘤颈直径无显著增大。
要点
- Active Seal技术使近端封闭区从21.5±6.0 mm显著延长至26.0±12.2 mm(p=.047)。
- 12个月内无1a型和3型内漏,仅1例(2.6%)因1b型内漏再干预。
- 12个月近端瘤颈直径无显著增大(1个月20.6±3.4 mm vs 12个月21.3±3.8 mm,p=.420)。
核心结论
- AFX的Active Seal技术在锥形近端瘤颈患者中显著延长了近端封闭区,12个月内未观察到1a型内漏和近端瘤颈扩张。
研究设计与样本
- 回顾性分析2016年1月至2020年8月日本17家医院使用AFX行EVAR的锥形近端瘤颈腹主动脉瘤患者,核心实验室确认纯锥形颈者39例纳入分析。
主要发现
- 共53例患者,核心实验室确认纯锥形颈者39例(平均年龄76.6±6.7岁,男性87.0%,平均瘤径52.0±8.0 mm)。
- 近端瘤颈于低位肾动脉处和瘤体近端边缘的平均直径分别为20.0±2.9 mm和27.5±4.9 mm,平均近端瘤颈长度21.5±6.0 mm。
- 除锥形颈外,15例(38.5%)存在说明书外使用;所有病例均使用VELA覆膜支架,另有9例(23.1%)需额外近端覆膜支架。
- Active Seal技术使近端封闭区从21.5±6.0 mm显著延长至26.0±12.2 mm(p=.047)。
- 36例完成12个月随访(1例失访,2例死于非动脉瘤相关原因),12个月内无1a型和3型内漏,仅1例(2.6%)因1b型内漏再干预;近端瘤颈直径1个月为20.6±3.4 mm,12个月为21.3±3.8 mm,无显著增大(p=.420)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the efficacy of the Active Seal technology employed in the AFX endovascular aortic aneurysm system (AFX), during endovascular aneurysm repair (EVAR) in patients with abdominal aortic aneurysms (AAAs) having a conical proximal neck. MATERIALS AND METHODS: A retrospective analysis of the EVAR for AAA with a conical proximal neck using the AFX was performed at 17 Japanese hospitals between January 2016 and August 2020. The conical proximal neck was defined as a cone-shaped proximal neck, with more than 10% diameter increase within a 15 mm length at the proximal landing zone. All anatomical analyses were performed in the core laboratory, and cases with parallel walls within the proximal neck adequate for the landing zone were excluded from the study. RESULTS: This study included 53 patients, but only 39 patients (mean age, 76.6 ± 6.7 years; 87.0% males; mean aneurysm diameter, 52.0 ± 8.0 mm) were analyzed after being characterized as having a pure conical neck by the core laboratory. The mean proximal neck diameters at the lower renal artery and proximal edge of the aneurysm were 20.0 ± 2.9 mm and 27.5 ± 4.9 mm, respectively. The mean proximal neck length was 21.5 ± 6.0 mm. Instructions for use violations other than the conical neck were observed in 15 patients (38.5%). The VELA cuff was used in all cases; however, additional proximal cuff was required in 9 more cases (23.1%). The Active Seal technology was able to significantly extend the proximal sealing zone from 21.5 ± 6.0 to 26.0 ± 12.2 mm (p = .047). Thirty-six patients completed the 12-month follow-up (one patient was lost to follow-up, and 2 patients died from causes unrelated to the aneurysm), and there were no type-1a and 3 endoleaks with only one reintervention (2.6%) related to type 1b endoleak in the 12-month period. Furthermore, there was no significant enlargement of the proximal neck diameter at 12 months (at 1 month: 20.6 ± 3.4 mm and at 12 months: 21.3 ± 3.8 mm; p = .420). CONCLUSION: The Active Seal technology of the AFX significantly extended the proximal seal zone and no type-1a endoleak and proximal neck dilation was observed in patients with conical proximal neck at 12 months.
引用
- Fujimura N, Obara H, Nagano T, et al. Early Clinical Outcomes of the Active Seal Technology of the AFX Endovascular Aortic Aneurysm System With the VELA Cuff for Patients With a Conical Proximal Neck. J Endovasc Ther. 2022. PMID: 35012389. doi:10.1177/15266028211070971
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。